Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standardized methods exist to estimate the pre...
Main Authors: | Elizabeth Pisani, Amalia Hasnida, Mawaddati Rahmi, Maarten Olivier Kok, Steven Harsono, Yusi Anggriani |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-08-01
|
Series: | JMIR Public Health and Surveillance |
Online Access: | https://publichealth.jmir.org/2021/8/e29309 |
Similar Items
-
Trade in substandard and falsified medicines
by: Hagen, N, et al.
Published: (2022) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01) -
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines.
by: Elizabeth Pisani, et al.
Published: (2024-01-01) -
Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review: 3 approved]
by: Elizabeth Pisani, et al.
Published: (2019-04-01) -
How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012)